z-logo
open-access-imgOpen Access
Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm
Author(s) -
Kasper Mønsted Pedersen,
Yunus Çolak,
Hans Carl Hasselbalch,
Stig E. Bojesen,
Børge G. Nordestgaard
Publication year - 2020
Publication title -
eclinicalmedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.915
H-Index - 20
ISSN - 2589-5370
DOI - 10.1016/j.eclinm.2020.100337
Subject(s) - medicine , myeloproliferative neoplasm , mendelian randomization , germline mutation , mutation , somatic cell , genotype , genetics , gene , myelofibrosis , bone marrow , biology , genetic variants

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom